Product Information

DORZOLAMIDE-TIMOLOL 2-0.5%(PF) is a generic product labeled by Aurobindo Pharma Limited, priced at $1.1012 per EA under NDC 65862094760. Its NADAC has been published 388 times since Jan 23, 2019.

DORZOLAMIDE-TIMOLOL 2-0.5%(PF)

Dorzolamide Hydrochloride and Timolol Maleate Preservative Free
$1.1012per EA

Strength

20; 5 mg/mL; mg/mL

NDC

65862094760

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA207630

On Market Since

7/24/2018

Pharmacological Classes

Adrenergic beta-Antagonists
Carbonic Anhydrase Inhibitor
Carbonic Anhydrase Inhibitors
beta-Adrenergic Blocker

Price Statistics

The NADAC for DORZOLAMIDE-TIMOLOL 2-0.5%(PF) has been published 388 times since Jan 23, 2019, and over the history we have for it it has declined 50.4%. The table below summarizes its recorded NADAC range and movement.

Current price$1.1012 per EA
All-time high$2.2200 (Feb 13, 2019)
All-time low$0.9746 (Nov 20, 2024)
52-week high$1.2479
52-week low$1.0471
Median price$1.7509
Average price$1.6387
Largest weekly change+40.7% (Jun 19, 2024)
Weeks tracked388
Tracking sinceJan 23, 2019

Price History

1W

0.0%

1M

+2.0%

3M

+4.2%

6M

-3.1%

1Y

-11.8%

3Y

-26.7%

5Y

-41.1%

All

-50.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Dorzolamide Hydrochloride and Timolol Maleate Preservative Free market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of DORZOLAMIDE-TIMOLOL 2-0.5%(PF)?

The current National Average Drug Acquisition Cost (NADAC) for DORZOLAMIDE-TIMOLOL 2-0.5%(PF), manufactured by Aurobindo Pharma Limited, is $1.1012 per EA (NDC 65862094760), effective Jun 24, 2026.

How has the price of DORZOLAMIDE-TIMOLOL 2-0.5%(PF) changed over time?

Over the history we have for it, the NADAC for DORZOLAMIDE-TIMOLOL 2-0.5%(PF) has declined 50.4%. It has been tracked across 388 weekly CMS publications since Jan 23, 2019.

What are the highest and lowest recorded NADAC prices for DORZOLAMIDE-TIMOLOL 2-0.5%(PF)?

Since Jan 23, 2019, the NADAC for DORZOLAMIDE-TIMOLOL 2-0.5%(PF) has ranged from a low of $0.9746 (Nov 20, 2024) to a high of $2.2200 (Feb 13, 2019), with a median of $1.7509 per EA.

Are there cheaper alternatives to DORZOLAMIDE-TIMOLOL 2-0.5%(PF)?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of DORZOLAMIDE-TIMOLOL 2-0.5%(PF), so no direct lower-cost alternative is listed.

Who manufactures DORZOLAMIDE-TIMOLOL 2-0.5%(PF)?

DORZOLAMIDE-TIMOLOL 2-0.5%(PF) (NDC 65862094760) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.